Holistic Considerations in Optimizing a Sterile Product Package to Ensure Container Closure Integrity

Reference

1. 1.↵
   United States Pharmacopeial Convention. <1207> Packaging Integrity Evaluation—Sterile Products.
2. 2.↵
   ASTM D2240 Standard Test Method for Rubber Property—Durometer Hardness.
3. 3.↵
   West Pharmaceutical Services Materials Development, Review of Historic Formulations, 2016.
4. 4.↵
   1. Ward I. M.,
   2. Sweeney J.

   An Introduction to the Mechanical Properties of Solid Polymers, 2nd ed.; John Wiley & Sons: Hoboken, NJ, 2004.
5. 5.↵
   1. Hiemenz P. C.,
   2. Lodge T. P.

   Polymer Chemistry, 2nd ed.; CRC Press: Boca Raton, FL, 2007.
6. 6.↵
   1. Zeng Q,
   2. Zhao C.

   Critical Consideration in Time-Dependent Evaluation and Modeling for Rubber Stopper Seal Performance. Presented at the PDA Europe Parenteral Packaging Meeting, Barcelona, Spain, 2017.
7. 7.↵
   United Seal & Rubber Co., Inc. Designing and Producing a High Performance Gasket or Seal. e-book, 2013.
8. 8.↵
   1. Chose T.

   Live Science, June 4, 2013, Live Science Publication, Tia Chose, Senior Writer.
9. 9.↵
   1. Dorison A.,
   2. Ludema K. C.

   Chapter 9. Lubricated Friction. In Mechanics and Chemistry In Lubrication, Dorison A., Ludema K. C., Eds.; Elsevier Science Publishers B. V.: Amsterdam, The Netherlands, 1985; Tribology Series Vol. 9, pp 178–197.
10. 10.↵
    1. Jones L. S.,
    2. Kaufmann A.,
    3. Middaugh C. R.

    Silicone Oil Induced Aggregation of Proteins. J. Pharm. Sci. 2005, 94 (4), 918–927.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Thirumangalathu R.,
    2. Krishnan S.,
    3. Ricci M. S.,
    4. Brems D. N.,
    5. Randolph T. W.,
    6. Carpenter J. F.

    Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous Solution. J. Pharm. Sci. 2009, 98 (9), 3167–3181.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Rey L.,
    2. May J.

    1. DeGrazio F.

    Chapter 9. Closure and Container Considerations in Lyophilization. In Freeze-Drying Lyophilization of Pharmaceutical and Biological Products, 2nd ed.; Rey L., May J., Eds.; Informa Healthcare: New York, 2010; Vol. 137.
13. 13.↵
    1. Vincent J.

    Chapter 1. Structural Biomaterials. In Basic Elasticity and Viscoelasticity, 3rd ed.; Princeton University Press: Princeton, NJ, 2012.
14. 14.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Quantitative and Mechanistic Measurements of Container/Closure Integrity: Viscoelastic Measurements of Elastomeric Closures. PDA J. Pharm. Sci. Technol. 1988, 42 (4), 57–61.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Davidson K.,
    2. Mangus J.

    Selecting and Verifying Integral Packaging Systems for Injectable Drug Products. Poster presented at the PDA Annual Meeting, Las Vegas, NV, 2015.
16. 16.↵
    PDA Technical Report No. 76. Identification and Classification of Visible Nonconformities in Elastomeric Components and Aluminum Seals for Parenteral Packaging; PDA: Bethesda, MD, 2016.
17. 17.↵
    1. Lam P.,
    2. Stern A.

    Visualization Techniques for Assessing Design Factors That Affect Interaction between Pharmaceutical Vials and Stoppers. PDA J. Pharm. Sci. Technol. 2010, 64 (2), 182–187.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Lysfjord J.

    1. Bogle F. W.,
    2. Asselta R. P.,
    3. Pepper L.

    Chapter 13. Crimp Sealing Parenteral Vials. In Practical Aseptic Processing: Fill Finish, Lysfjord J., Ed.; PDA and Davis Healthcare International Publishing: Bethesda, MD and River Grove, IL, respectively, 2009; Vol. 1, pp 261–273.

    OpenUrl
19. 19.↵
    1. Mathaes R.,
    2. Mahler H. C.,
    3. Buettiker J. P.,
    4. Roehl H.,
    5. Lam P.,
    6. Brown H.,
    7. Luemkemann J.,
    8. Adler M.,
    9. Huwyler J.,
    10. Streubel A.,
    11. Mohl S.

    The Pharmaceutical Vial Capping Process: Container Closure Systems, Capping Equipment, Regulatory Framework, and Seal Quality Tests. Eur. J. Pharm. Biopharm. 2016, 99, 54–64.

    OpenUrlPubMed
20. 20.↵
    1. Mathaes R.,
    2. Mahler H.,
    3. Roggo Y.,
    4. Ovadia R.,
    5. Lam P.,
    6. Stauch O.,
    7. Vogt M.,
    8. Roehl H.,
    9. Huwyler J.,
    10. Mohl S.,
    11. Streubel A.

    Impact of Vial Capping on Residual Seal Force and Container Closure Integrity. PDA J. Pharm. Sci. Technol. 2016, 70 (1), 12–29.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Asselta R.

    Parenteral Vial Sealing and Integrity Webinar. Genesis Packaging Technologies: Exton, PA; January 2017.
22. 22.↵
    United States Pharmacopeia. <1207.1> Package Integrity Testing in the Product Life Cycle—Test Method Selection and Validation. United States Pharmacopeial Convention: Rockville, MD, 2016.
23. 23.↵
    United States Pharmacopeia. <1207> Section 5. Product-Package Quality Requirements and the Maximum Allowable Leakage Limit. United States Pharmacopeial Convention: Rockville, MD, 2016.
24. 24.↵
    1. Paskiet D.,
    2. Asselta R.

    Qualifying Integral Container Closure Systems. Presented at the PDA Annual Meeting, San Antonio, TX, 2014.
25. 25.↵
    1. Morton D. K.,
    2. Lordi N. G.

    Residual Seal Force Measurements of Parenteral Vials. I. Methodology. PDA J. Pharm. Sci. Technol. 1988, 42 (1), 23–29.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Mathaes R.,
    2. Mahler H.,
    3. Roggo Y.,
    4. Huwyler J.,
    5. Eder J.,
    6. Fritsch K.,
    7. Posset T.,
    8. Mohl S.,
    9. Streubel A.

    Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity in GMP Drug Product Manufacturing. PDA J. Pharm. Sci. Technol. 2016, 70 (2), 109–119.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    FDA Guidance for Industry. Drug Stability Guidelines. Section C3. Temperature. December 9, 2008.
28. 28.↵
    Fisher BioServices. Cold Chain Qualification: 5 Questions You Must Ask When Shipping Biologics, e-book, August 14, 2013.
29. 29.
    1. Zuleger B.,
    2. Werner U.,
    3. Kort A.,
    4. Glowienka R.,
    5. Wehnes E.,
    6. Duncan D.

    Container/Closure Integrity Testing and the Identification of a Suitable Vial/Stopper Combination for Low-Temperature Storage at −80° C. PDA J. Pharm. Sci. Technol. 2012, 66 (5), 453–465.

    OpenUrlAbstract/FREE Full Text